Gherman A, Căinap C, Constantin A-M, Cetean S, Căinap SS. Molecular targeted treatment of metastatic colorectal cancer: the cardiovascular adverse effects of Bevacizumab and Cetuximab. Med Pharm Rep [Internet]. 2017 Oct. 30 [cited 2025 Oct. 6];90(4):377-84. Available from: https://medpharmareports.com/index.php/mpr/article/view/745